Bayer (BAYRY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec1

Bayer AG Receives FDA Approval to Expand Compatibility of MEDRAD Centargo CT Injection System

16:30

Nov23

Bayer's Asundexian Achieves Primary Endpoint in Phase 3 Clinical Study

15:53

Nov19

Bayer Receives EU Approval for Lynkuet™

07:33

Nov12

Bayer released FY2025 9 Months Earnings on November 11 EST, with actual revenue of USD 38.77 B and EPS of USD 0.0106

04:00

Bayer released FY2025 Q3 earnings on November 11 (EST), actual revenue USD 11.33 B (forecast USD 11.4 B), actual EPS USD -0.2873

04:00

Nov4

Bayer to Release FY2025 Q3 Earnings on November 11 (EST), Market Forecast Revenue USD 11.23 B

00:06

Schedules & Filings

Schedules

Filings

Nov11

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.33 B, Net Income -1.129 B, EPS -0.2873

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 12.57 B, Net Income -232.94 M, EPS -0.0592

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.87 B, Net Income 1.406 B, EPS 0.3572

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change